fibrous dysplasia disorder normal bone marrow replaced fibrous tissue resulting formation bone weak prone expansion result complications result fracture deformity functional impairment disease occurs along broad clinical spectrum ranging asymptomatic incidental lesions severe disabling disease disease affect one bone monostotic multiple polyostotic bones may occur isolation combination café au lait skin macules hyperfunctioning endocrinopathies termed rarely fibrous dysplasia may associated intramuscular myxomas termed mazabrauds fibrous dysplasia rare known fibrous dysplasia form cancer fibrous dysplasia mosaic disease involve part combination craniofacial axillary andor appendicular type severity complications therefore depend location extent affected skeleton clinical spectrum broad ranging isolated asymptomatic monostotic lesion discovered incidentally severe disabling disease involving practically entire skeleton leading loss vision hearing andor mobilitycitation needed individual bone lesions typically manifest first years life expand childhood vast majority clinically significant bone lesions detectable age years new almost clinically significant bone lesions appearing age total body scintigraphy useful identify determine extent bone lesions performed patients suspected fibrous children fibrous dysplasia appendicular skeleton typically present limp pain andor pathologic fractures frequent fractures progressive deformity may lead difficulties ambulation impaired mobility craniofacial skeleton fibrous dysplasia may present painless lump facial asymmetry expansion craniofacial lesions may lead progressive facial deformity rare cases patients may develop vision andor hearing loss due compromise optic nerves andor auditory canals common patients mccunealbright syndrome associated growth hormone fibrous dysplasia commonly involves spine may lead scoliosis rare instances may untreated progressive scoliosis one features fibrous dysplasia lead early fatality bone pain common complication fibrous dysplasia may present age commonly develops adolescence progresses bone marrow stromal cells fibrous dysplasia produce excess amounts phosphateregulating hormone fibroblast growth leading loss phosphate patients hypophosphatemia may develop ricketsosteomalacia increased fractures bone fibrous dysplasia mosaic disease resulting postzygotic activating mutations gnas locus codes α subunit gs g proteincoupled bone constitutive gsα signaling results impaired differentiation proliferation bone marrow stromal proliferation cells causes replacement normal bone marrow fibrous tissue bony trabeculae abnormally thin irregular bony spicules biopsycitation needed fibrous dysplasia hereditary never case genetic inheritance parent childcitation needed xray fibrous dysplasia appears bubbly lytic lesions ground glass appearance computerized tomography ct magnetic resonance imaging mri scans may used determine extensively bones affected ct better demonstrate typical ground glass appearance highly specific radiological finding mri show cystic areas fluid bone scan uses radioactive tracers injected bloodstream damaged parts bones take tracer show brightly scan biopsy uses hollow needle remove small piece affected bone laboratory analysis diagnose fibrous dysplasia definitelycitation needed treatment fibrous dysplasia mainly palliative focused managing fractures preventing deformity medications capable altering disease course intravenous bisphosphonates may helpful treatment bone pain clear evidence strengthen bone lesions prevent surgical techniques effective bone grafting curettage plates screws frequently ineffective polyostotic version fibrous dysplasia often effective monostotic fibrous intramedullary rods generally preferred management fractures deformity lower progressive scoliosis generally managed standard instrumentation fusion surgical management craniofacial skeleton complicated frequent postoperative fd regrowth focus correction functional prophylactic optic nerve decompression increases risk vision loss managing endocrinopathies critical component management fd patients fibrous dysplasia evaluated treated endocrine diseases associated syndrome particular untreated growth hormone excess may worsen craniofacial fibrous dysplasia increase risk untreated hypophosphatemia increases bone pain risk httpsenwikipediaorgwikifibrousdysplasiaofbone